Order Article Reprints

Kudriavtsev AV, Vakhrusheva AV, Kryuchkov NA, Frolova ME, Blagodatskikh KA, Ivanishin TV, Djonovic M, Romanovskaya-Romanko EA, Kovalenko AN, Lioznov DA, et al. Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial. Vaccines. 2023; 11(2):326. https://doi.org/10.3390/vaccines11020326

Kudriavtsev, Aleksandr V., Anna V. Vakhrusheva, Nickolay A. Kryuchkov, Maria E. Frolova, Konstantin A. Blagodatskikh, Taras V. Ivanishin, Milana Djonovic, Ekaterina A. Romanovskaya-Romanko, Anton N. Kovalenko, Dmitry A. Lioznov, and et al. 2023. "Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial" Vaccines 11, no. 2: 326. https://doi.org/10.3390/vaccines11020326

Kudriavtsev, A. V., Vakhrusheva, A. V., Kryuchkov, N. A., Frolova, M. E., Blagodatskikh, K. A., Ivanishin, T. V., Djonovic, M., Romanovskaya-Romanko, E. A., Kovalenko, A. N., Lioznov, D. A., Zubkova, T. G., Teplykh, S. V., Oseshnyuk, R. A., Stukova, M. A., Isaev, A. A., & Krasilnikov, I. V. (2023). Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial. Vaccines, 11(2), 326. https://doi.org/10.3390/vaccines11020326